CORE awarded $50K breast cancer health inequities research grant

August 1, 2023

Share this Article
Facebook

A doctor providing a woman with a mammogram

Back to CORE's website

The Providence Center for Outcomes Research & Education (CORE) has been awarded a $50,000 grant to advance its growing body of research on breast cancer health inequities.

The funding from the Preparedness and Treatment Equity Coalition (PTEC) and Gilead Sciences will help CORE examine the pathways by which healthcare experiences, including discrimination in the healthcare setting, contribute to gaps in mammography. CORE researchers will also assess the ways in which these experiences may differ for those included and excluded in health system breast cancer screening metrics.

“We are excited to continue our important work of understanding and ultimately addressing the underlying factors that contribute to disparities in breast cancer outcomes among people of color and other groups experiencing inequities in the U.S. health system,” said Monique Gill, a research scientist at CORE.

CORE is among three U.S. research teams receiving similar awards from PTEC. Read the full press release at PTEC’s website: https://ptechealth.org/bc-inequities-press-release

Related resources

Blog post: Addressing language disparities in breast cancer screening
Learn more about the Preparedness & Treatment Equity Coalition

Providence physician receives lifetime achievement award

The American Society of Nephrology is honoring Dr. Katherine Tuttle with one of health care research’s most...

Breast cancer survivor, artist gives back to Providence

Portland painter credits the support of Providence providers and creating art for helping her recover and h...

Other content in this Stream

New report highlights the breadth & impact of research at Providence

CORE awarded $50K breast cancer health inequities research grant

Previous Article

Next Article

Other content in this Stream

Providence researchers conducted over 1500 studies in 2025, according to a new report from the Providence Research Network. Check out the 2025 research program brief to learn more!

Providence is joining a nationwide, federally funded research project to develop a Large Health Behavior Model.

Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.

A new Providence study identifies barriers to colorectal cancer screening among racially diverse communities and is helping to shape outreach efforts to improve screening rates.

A new study focused on stories will change health outcomes for Black women.

A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

New research from CORE and Providence Genomics asks whether how and where genetic testing is offered affects whether patients say “yes.”

The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.

After Virginia Kuo was diagnosed with lung cancer, Providence Swedish experts were committed to helping this mom of three have the life she envisioned with her husband and family. Learn more

The MR Repair trial ranks Providence Swedish's echocardiography lab as a top-performing site for the advancement of mitral valve care. Learn more.

Providence Montana - HealthBreak - RESOLVE RESOLVE is the name of a new collaborative between Providence Health, Providence St. Patrick Hospital, and the University of Montana aimed at improving heal

A recent Beckers Health interview with Providence researcher Kristi Roybal, PhD, showcases the launch of an interactive toolkit to help health systems boost equity in medical research.

Learn how Providence researchers are providing valuable real-world data on the transition to next-generation nursing models.

Pfizer Global Medical Grants has awarded $250,000 for Providence to use Prov-GigaPath to predict cancer mutations among Oregon patients

CORE's 2025 Annual Report showcases how CORE and its cross-sector partners are working to advance health and health equity across the Western U.S. and beyond.

A generous grant from the Kuni Foundation is helping Providence researchers better understand lung cancer symptoms and improve patients' quality of life.

The study may redefine care for many people at the earliest stage of their treatment.